• Objective: To determine whether the conclusions of a 1991 study, which showed that adults with acute lymphoblastic leukemia in first remission had similar leukemia-free survival rates when treated with chemo-therapy or HLA-identical sibling bone marrow trans-plantation, remain valid after more than 4 years of additional follow-up. • Design: Retrospective comparison of two cohorts of patients using left-truncated Cox regression to adjust for differences in baseline characteristics and time to treatment. • Setting and Patients: Chemotherapy recipients were 484 consecutive patients with acute lymphoblastic leu-kemia in first remission treated in 44 hospitals in Ger-many that were participating in two consecutive trial
From 1994 to 2000, 154 adults with Philadelphia chromosome-positive (Ph+) and/or BCR-ABL(+) acute ly...
To evaluate the results of autologous stem cell transplantation ( ASCT) in a large population of adu...
Complete remission (CR) rates in adults with acute lymphoblastic leukemia (ALL) are 63%-86 % (Table ...
• Objective: To compare efficacy of intensive pos-tremission chemotherapy with allogeneic bone marro...
About one half of adults with acute lymphoblastic leukemia are not cured of the disease and ultimate...
Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't;BACKGROUND ...
This retrospective study, including 118 patients with acute lymphoblastic leukemia (ALL) aged greate...
The case histories of 293 adolescent and adult patients with acute lymphoblastic leukemia (ALL) firs...
This retrospective study, including 118 patients with acute lymphoblastic leukemia (ALL) aged greate...
This report presents retrospective analysis of 215(median age 21 years; male 75 percent) adult ALL p...
The Southwest Oncology Group conducted a study of acute lymphoblastic leukemia (ALL) in adults over ...
Group conducted two clinical trials for the treatment of newly diagnosed patients with acute lymphob...
In a prospective multicenter study. 368 acute lymphoblas-tic leukemia (ALL) patients aged 1 5 to 65 ...
Allogeneic hematopoietic cell transplantation is widely used to treat adults with high-risk acute ly...
Background: Acute lymphoblastic leukemia is a lymphoid malignancy, resulting from autonomous prolife...
From 1994 to 2000, 154 adults with Philadelphia chromosome-positive (Ph+) and/or BCR-ABL(+) acute ly...
To evaluate the results of autologous stem cell transplantation ( ASCT) in a large population of adu...
Complete remission (CR) rates in adults with acute lymphoblastic leukemia (ALL) are 63%-86 % (Table ...
• Objective: To compare efficacy of intensive pos-tremission chemotherapy with allogeneic bone marro...
About one half of adults with acute lymphoblastic leukemia are not cured of the disease and ultimate...
Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't;BACKGROUND ...
This retrospective study, including 118 patients with acute lymphoblastic leukemia (ALL) aged greate...
The case histories of 293 adolescent and adult patients with acute lymphoblastic leukemia (ALL) firs...
This retrospective study, including 118 patients with acute lymphoblastic leukemia (ALL) aged greate...
This report presents retrospective analysis of 215(median age 21 years; male 75 percent) adult ALL p...
The Southwest Oncology Group conducted a study of acute lymphoblastic leukemia (ALL) in adults over ...
Group conducted two clinical trials for the treatment of newly diagnosed patients with acute lymphob...
In a prospective multicenter study. 368 acute lymphoblas-tic leukemia (ALL) patients aged 1 5 to 65 ...
Allogeneic hematopoietic cell transplantation is widely used to treat adults with high-risk acute ly...
Background: Acute lymphoblastic leukemia is a lymphoid malignancy, resulting from autonomous prolife...
From 1994 to 2000, 154 adults with Philadelphia chromosome-positive (Ph+) and/or BCR-ABL(+) acute ly...
To evaluate the results of autologous stem cell transplantation ( ASCT) in a large population of adu...
Complete remission (CR) rates in adults with acute lymphoblastic leukemia (ALL) are 63%-86 % (Table ...